Selegiline monotherapy in the treatment of Parkinson's disease

Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

European journal of neurology·2009

A comparison of Parkinson's disease symptoms and self-reported functioning and well being.

Parkinsonism & related disorders·2008

Topiramate in essential tremor: a double-blind, placebo-controlled trial.

Neurology·2006

Apolipoprotein E controls the risk and age at onset of Parkinson disease.

Neurology·2004

Advances in the treatment of Parkinson's disease.

Drugs of today (Barcelona, Spain : 1998)·2004

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

Neurology·2003

Associations of Antibodies Against Several Infections With Alzheimer Disease Neuropathology: A Prospective Cohort Study Analysis.

Neurology·2026

Midlife and Late-Life Alzheimer Disease Blood Biomarkers and 11-Year Cognitive Decline.

Neurology·2026

A Primer on COL4A1/COL4A2-Related Cerebral Small Vessel Disease for Neurologists.

Neurology·2026

Recommendations for the Management of Spontaneous Intracranial Hypotension With Spinal Longitudinal Epidural CSF Collection: A Delphi Study.

Neurology·2026

Incidence and Post-Stroke Survival in the Normandy Stroke Population-Based Study (2017-2022): Impact of Time-Based Versus Tissue-Based Definitions.

Neurology·2026

Role of APOE ɛ4 and ɛ2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity: The LifeAfter90 Study.

Neurology·2026

Patients' views and experiences about unused medications and potential interventions to reduce medication waste.

Exploratory research in clinical and social pharmacy·2026

Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system.

Pediatrics and neonatology·2026

Current Pharmacovigilance Outsourcing Practices in Arab Countries.

Drug safety·2026

Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025.

Current drug safety·2026

Ocular safety signals of sphingosine-1-phosphate receptor modulators in postmarketing surveillance.

Frontiers in pharmacology·2026

Adaptation and factor analysis of a buprenorphine attitudes scale: Association with attitudes and dispensing practices among community pharmacists in Puerto Rico.

Journal of the American Pharmacists Association : JAPhA·2026

Related Experiment Videos

Selegiline monotherapy in the treatment of Parkinson's disease

Related Concept Videos

Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

A comparison of Parkinson's disease symptoms and self-reported functioning and well being.

Topiramate in essential tremor: a double-blind, placebo-controlled trial.

Apolipoprotein E controls the risk and age at onset of Parkinson disease.

Advances in the treatment of Parkinson's disease.

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

Associations of Antibodies Against Several Infections With Alzheimer Disease Neuropathology: A Prospective Cohort Study Analysis.

Midlife and Late-Life Alzheimer Disease Blood Biomarkers and 11-Year Cognitive Decline.

A Primer on COL4A1/COL4A2-Related Cerebral Small Vessel Disease for Neurologists.

Recommendations for the Management of Spontaneous Intracranial Hypotension With Spinal Longitudinal Epidural CSF Collection: A Delphi Study.

Incidence and Post-Stroke Survival in the Normandy Stroke Population-Based Study (2017-2022): Impact of Time-Based Versus Tissue-Based Definitions.

Role of APOE ɛ4 and ɛ2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity: The LifeAfter90 Study.

Patients' views and experiences about unused medications and potential interventions to reduce medication waste.

Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system.

Current Pharmacovigilance Outsourcing Practices in Arab Countries.

Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025.

Ocular safety signals of sphingosine-1-phosphate receptor modulators in postmarketing surveillance.

Adaptation and factor analysis of a buprenorphine attitudes scale: Association with attitudes and dispensing practices among community pharmacists in Puerto Rico.

Related Experiment Videos

Selegiline monotherapy in the treatment of Parkinson's disease

Related Concept Videos

Related Articles